Related Experiment Video
Updated: Jul 5, 2026
Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy
Published on: January 25, 2019
Stem cell use for cardiac diseases as of 2008
Jasmin Ortak1, Ibrahim Akin, Stephan Kische
1Department of Medicine, Division of Cardiology at the University Hospital Rostock, Rostock School of Medicine, Ernst-Heydemann-Strasse 6, Rostock, Germany.
Insights
Cell therapy shows promise for regenerating heart tissue damaged by heart failure and coronary artery disease. However, further research is needed to confirm its long-term efficacy and safety as a heart disease treatment.
Area of Science:
- Regenerative Medicine
- Cardiovascular Biology
- Cell-Based Therapies
Background:
- Congestive heart failure and coronary artery disease are leading causes of death.
- Therapeutic advances have been limited, highlighting the need for novel treatments.
- Recent research suggests the potential for regenerating damaged heart tissue.
Purpose of the Study:
- To review the current evidence for cell-based myocardial regeneration.
- To explore the proposed mechanisms of action for cell therapy in heart disease.
- To identify challenges and future directions for clinical cell-based strategies.
Main Methods:
- Review of preclinical and clinical studies on cell-based myocardial regeneration.
- Analysis of proposed mechanisms underlying the beneficial effects of cell therapy.
- Evaluation of the sustained efficacy and safety of different cell types in clinical trials.
Main Results:
- Growing evidence supports the safety and efficacy of cell-based myocardial regeneration.
- Multiple mechanisms are proposed for the beneficial effects of cell therapy.
- Early promising results for some cell types have not been consistently replicated in robust studies.
Conclusions:
- Cell-based therapy holds potential as an adjunctive treatment for heart disease.
- Unanswered questions regarding efficacy and mechanisms require further investigation.
- Continued research and development are crucial for advancing potent cell-based strategies for clinical use.
Abstract:
Congestive heart failure and coronary artery disease are the leading causes of morbidity and mortality in the western society despite substantial therapeutic advances in the last half century. Only very recently have studies arisen that support possibility of regenerating tissue of damaged human organs including the heart. In this regard, there is growing preclinical and clinical evidence demonstrating the safety and efficacy of cell-based myocardial regeneration using a variety of cell lines. Different mechanisms have been proposed to explain the beneficial effects of cell-based therapy. The beneficial effects of cell therapy may involve multiple mechanisms. The encouraging results of early clinical cell therapy studies have not been sustained by subsequent robust studies for all cell types. These findings suggest that many unanswered questions need to be addressed before cell therapy becomes an acceptable adjunctive treatment for heart disease. Future setbacks are likely, but both clinicians and basic scientists will eventually introduce more potent cell-based strategies into the clinical arena.
Related Concept Videos
01:21Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
01:22iPS Cell Differentiation
01:17Stem Cell Culture
00:57Embryonic Stem Cells
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
00:58Embryonic Stem Cells
01:13Induced Pluripotent Stem Cells